ArticleBMC cancer2017

Phase I study of oral ridaforolimus in combination with paclitaxel and carboplatin in patients with solid tumor cancers.

Hye Sook Chon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.